Related Experiment Video
Updated: May 18, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[Dutch guideline for cardiovascular risk management: a consensus model]
1Maastricht Universitair Medisch Centrum, afd. Interne Geneeskunde, Maastricht, the Netherlands. aa.kroon@mumc.nl
This commentary reviews hypertension treatment guidelines, emphasizing age-related cardiovascular risk and considering hyperlipidemia management in obesity and diabetes. It suggests measuring apolipoprotein B-100 or non-HDL cholesterol for targeted interventions.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- The 2011 hypertension guideline revision is based on a consensus model.
- Recent studies highlight the importance of age in cardiovascular risk stratification.
- Hyperlipidemia in obesity and diabetes requires specific screening and treatment considerations.
Purpose of the Study:
- To discuss the role of age in cardiovascular risk stratification for hypertension.
- To evaluate the significance of hyperlipidemia management in obese and diabetic patients.
- To advocate for specific lipid measurements in clinical practice.
Main Methods:
- Commentary and analysis of existing guideline data.
- Review of recent scientific literature on hypertension and hyperlipidemia.
- Discussion of consensus-based recommendations.
Main Results:
- Hypertension treatment should be considered for both very old and very young individuals.
- Apolipoprotein B-100 or non-HDL cholesterol measurement is recommended for screening and treatment targets in hyperlipidemia.
- The guideline revision reflects a consensus approach to cardiovascular risk management.
Conclusions:
- Age is a critical factor in cardiovascular risk stratification and hypertension management.
- Specific lipid markers are essential for effective hyperlipidemia treatment in at-risk populations.
- The discussed aspects of the guideline aim to improve patient outcomes in cardiovascular and metabolic diseases.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Rheumatic Heart Disease III: Medical Management
Pre-Procedural Guidelines for Assessing Blood Pressure
Heart Failure V: Medical Management
Rheumatic Heart Disease IV: Nursing Management